News

Defective sperm doubles the risk of preeclampsia

Oct 9, 2024

We’re excited to share new findings from Lund University, led by ReproUnion researcher Aleksander Giwercman. For the first time, researchers have linked specific sperm defects to pregnancy complications and adverse effects on the child’s health. The study shows that DNA damage in the father’s sperm doubles the risk of preeclampsia in women undergoing IVF and increases the likelihood of premature birth.

With involuntary infertility becoming more prevalent and IVF treatments rising (5,614 children were born via IVF in Sweden in 2021), these findings shed light on why some pregnancies face complications. While women undergoing assisted reproduction are known to have higher risks of preeclampsia, miscarriages, and premature births, the underlying causes have not been fully understood.

High DNA fragmentation in sperm, which is related to the father’s general health, is a key factor. Oxidative stress, age, smoking, obesity, and infections are all contributing elements—but this condition is potentially treatable.

Aleksander Giwercman emphasizes that DFI analysis should become standard across all fertility clinics to provide answers to couples struggling with conception and to help identify high-risk pregnancies.

Amelie Stenqvist add – “Next steps include identifying the group of men who benefit most from methods that prevent and address sperm DNA damage, with the goal of reducing pregnancy complications,”.

If you want to now more about Amelie Stenqvists work check out this short video: https://lnkd.in/diGRebTy

To learn more read the official press release from Lund University

MORE NEWS


Welcome back Mette Bach Dyremose

We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion's communication efforts! With over 20 years of experience in strategic communication, business development, and life sciences,...

read more

RUBIC Seminar – The Team Makes the Dream Work

On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient recruitment, clinical visits, sample preparation, and data analysis as well as other colleagues in contact with RUBIC in their...

read more

Tour de Health

Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his presence highlights the growing political attention on reproductive...

read more